在缺乏服务的患者群体中,坚持服用抗发作药物
Ana Gonzalez1, Dilip Pandey1, Nicole Digiannantonio1
1University of Illinois at Chicago, 912 S. Wood St, Chicago, IL 60612, USA.
Epilepsy & behavior : E&B
|November 21, 2023
概括
在患者中,药物不服药是常见的,特别是那些社会经济地位较低的人. 护士主导的干预措施显著改善了守,强调了患者教育对控制的重要性.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 抗发作药物 (ASM) 对70%的患者有效,但在26-79%的病例中,不坚持导致突破性发作.
- 不良的遵守与年龄,教育,剂量频率,遗忘,副作用和社会经济地位等因素有关,特别是在服务不足的人群中.
研究的目的:
- 在例行随访期间评估成年患者的药物坚持.
- 确定患者教育在减少缺乏服务的患者群体中不遵守的作用.
主要方法:
- 在伊利诺伊大学医院 (2016-2020年) 的286名成年患者的回顾性图表审查.
- 通过电子医疗记录 (RedCap系统) 收集的数据包括人口统计,/发作分类,药物和坚持.
- 使用STATA 17.0进行的统计分析,包括基平方和t测试.
主要成果:
- 根据ASM水平,38.81%的患者是不坚持的.
- 更高的收入 (5万美元+) 和高加索种族与坚持相关 (p=0.009,p=0.006).
- 护士的电话在70名不坚持的患者中增加了80.39%的坚持;在大学受过教育的患者中观察到更好的坚持的趋势.
结论:
- 超过三分之一的患者在例行访问期间表现出不坚持.
- 较低的社会经济地位和教育与较高的不遵守率相关.
- 有针对性的教育和干预措施,如护士电话,对于改善药物守和预防发作至关重要.
更多相关视频
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
17.3K
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.7K
相关概念视频
01:08Antiepileptic Drugs: Sodium Channel Blockers
597
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
597
01:24Arteries of the Lower Limbs
192
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
192
01:17Antiepileptic Drugs: Calcium Channel Blockers
417
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
417
01:20Antiepileptic Drugs: Potassium Channel Activators
188
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
188
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
317
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
317
01:28Drug Therapy
46
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
46